PHOENIX and VANCOUVER, British Columbia, Feb. 24, 2014 (GLOBE NEWSWIRE) -- Eternity Healthcare (OTCBB:ETAH) or the "Company" a Medical Device and Diagnostic company today announced to sell 800,000 Common Stock for the total proceed of $500,000.00 USD exempt for registration under the Securities and Exchange under the Regulation S. The shares will be issued to international investor's and will be restricted under 144 rules for reselling. The Company plans to close the financing within 45 days, unless extended by mutual agreement. The proceeds from this financing will be used to finance the research and development of current products and products in the pipeline.
Dr. Salari, CEO stated "With the closing of this financing Eternity Healthcare will have the resources available to initiate development of an alternative saliva based glucose monitoring test. Using two parameters of diabetes physiological changes, the device will provide more accurate results for diabetics and their blood sugar level". Dr. Salari continued "the additional funds will also allow the company to continue our product pipeline marketing efforts".
About Eternity Healthcare Inc. (OTCBB:ETAH) is a biopharmaceutical company with technologies in diagnostics and medical devices. We are currently focused on products to target diabetes need including a needle-free injection device. Our products are sold to healthcare professionals, for use in physicians' offices, pharmacies, and to consumers directly. With a large number of additional diagnostic tests and medical devices for metabolic diseases, cardiovascular, neurodegenerative and cancer are under development at Eternity Healthcare Inc. www.eternityhealthcare.com
Safe Harbor Statement This release includes forward-looking statements. These forward-looking statements generally can be identified by phrases such as ETAH or its management "believes," "expects," "anticipates," "foresees," "forecasts," "estimates" or other words or phrases of similar import. Similarly, statements herein that describe the Company's business strategy, outlook, objectives, plans, intentions or goals also are forward-looking statements. All such forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those in forward-looking statements.
CONTACT: Investor Relations Contact: Bryan Andrew Wall Street Media Group Inc. (480) 588-8658 email@example.comSource:Eternity Healthcare, Inc.